期刊文献+

HPV、TCT及阴道镜在宫颈癌前病变筛查中的意义 被引量:7

The Significance of HPV,TCT and Colposcopy in the Screening of Cervical Intraepithelial Neoplasia
下载PDF
导出
摘要 目的探讨HPV、TCT以及阴道镜在宫颈癌前病变筛查中的作用。方法将我院自愿接受宫颈癌筛查患者分别进行HPV、TCT检测及阴道镜下活检。结果 HPV检测符合率为94.8%,TCT检出符合率为90.4%,两种方法差异无统计学意义(P>0.05),且HPV、TCT联合阴道镜下活检宫颈癌前病变检出率为100%。结论 HPV、TCT联合阴道镜下活检是宫颈癌前病变筛查的高效手段。 ObjectiveTo explore the role of HPV, TCT and the screening of cervical intraepithelial neoplasia .Methods HPV, TCT test and biopsy of cervical cancer screening patients were performed in our hospital.Results The compliance rate of HPV detection was 94.8%, the rate of TCT was 90.4%, the difference was not statisticaly significant (P〉0.05), and the detection rate of cervical intraepithelial neoplasia was 100%, HPV, TCT combined with biopsy.Conclusion HPV, TCT combined with biopsy is an effective method for screening cervical intraepithelial neoplasia .
作者 张蓉
出处 《中国卫生标准管理》 2016年第11期183-184,共2页 China Health Standard Management
关键词 宫颈癌 HPV TCT 阴道镜 Cervical cancer HPV TCT Vaginal
  • 相关文献

参考文献8

二级参考文献51

  • 1马博文,郭云泉,马丽骊.液基薄层细胞技术对宫颈上皮细胞异常筛查作用的研究[J].中华病理学杂志,2004,33(3):287-290. 被引量:84
  • 2马英,于成银,冷志,邓仁洪,林明杰.HPV感染与宫颈鳞状上皮内病变及宫颈癌关系探讨[J].重庆医学,2004,33(7):1011-1013. 被引量:11
  • 3李力.宫颈癌与人乳头瘤病毒感染[J].中国实用妇科与产科杂志,2006,22(1):13-15. 被引量:35
  • 4钱德英.重视宫颈癌前病变筛查的质量管理控制[J].中国实用妇科与产科杂志,2007,23(7):497-498. 被引量:102
  • 5Solomon D, Schiffman M, Tarone R. Comparison of three management strategies for patients with atypical squamous cells of undetermined significance:baseline results from a randomized trial[J]. Natl Cancer Inst, 2009, 93(4): 293-299.
  • 6Jenkins D. A review of cross-protection cancer vaccine Importance of virological and clinical endpoints and implications for mass vaccination in cervical cancer prevention [J]. Gynecol Oncol, 2008, 110(3): 18-25.
  • 7De Wilde J, Wilting S M, Meijer C J, et al. Gene expression profiling to identify markers associated with deregulated hTERT in HPV-transformed keratinocytes and cervical cancer[J]. Int J Cancer, 2008, 122(4): 877-888.
  • 8Cuzick J, Arbyn M, Sankaranarayanan of human papillomavirus-based and o R, the et al. Overview r novel options for cervical cancer screening in developed and developing countries[J]. Vaccine, 2008, 26(10): K29-K41.
  • 9Castle P E, Cox J T, Schiffman M, et al. Factors influencing histologic confirmation of high-grade squamous intraepithelial lesion cytology[J]. Obstet Gynecol, 2008, 112(3): 637-645.
  • 10Naucler P, Ryd W, Tomberg S, et al. Efficacy of HPV DNA testing with cytology triage and/or repeat HPV DNA testing in primary cervical cancer screening[J]. J Natl Cancer Inst, 2009, 101(1): 88-89.

共引文献128

同被引文献42

引证文献7

二级引证文献43

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部